Register
Blood 2018 Apr 5
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia.   

Related Questions

How do you decide between blinatumomab or traditional chemotherapy in combination with TKI for upfront treatment of adult patients with Ph + ALL?
New comment by Medical Oncologist at Duke University School of Medicine ( December 4, 2020)
What is your opinion on GRAAPH-2005 - lower intensity chemo regimen with TKI had improved outcomes as compared to TKI + hyper cvad? 
Copyright © 2025 theMednet
All Rights Reserved.